BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10756506)

  • 1. Rationale for hormone replacement therapy in atherosclerosis prevention.
    Wagner JD
    J Reprod Med; 2000 Mar; 45(3 Suppl):245-58. PubMed ID: 10756506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal bleeding patterns in women receiving hormone replacement therapy. Impact of various progestogen regimens.
    Thorneycroft IH; Gibbons WE
    J Reprod Med; 1999 Feb; 44(2 Suppl):209-14. PubMed ID: 11392034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
    Gompel A
    Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endometrium: effects of estrogen and estrogen-progestogen replacement therapy.
    Samsioe G
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():84-92. PubMed ID: 7874191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular effects of gestagens--biochemistry versus epidemiology].
    Kuhl H
    Zentralbl Gynakol; 1999; 121(2):67-78. PubMed ID: 10096172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogen therapies: differences in clinical effects?
    Wiegratz I; Kuhl H
    Trends Endocrinol Metab; 2004 Aug; 15(6):277-85. PubMed ID: 15358281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and coronary heart disease.
    Ettinger B
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):741-57. PubMed ID: 2092240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern tendencies in HRT of patients treated for endometrial cancer].
    Ivanov C
    Akush Ginekol (Sofiia); 2009; 48(2):20-2. PubMed ID: 20198772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogens and target tissues: vascular systems.
    Mueck AO; Seeger H
    Maturitas; 2009 Apr; 62(4):356-61. PubMed ID: 19157733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of effect of progestogen on bone.
    Lindsay R
    J Reprod Med; 1999 Feb; 44(2 Suppl):215-20. PubMed ID: 11392035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.